The Promise and the hype of 'personalised medicine'
Personalised medicine is widely considered as the way of the future for medicine. However, progress in cancer, with a few outstanding exceptions, has fallen below expectations because of the challenges of tumour heterogeneity and clonal evolution. In both benign and malignant disease, diseases cause...
Autor principal: | Maughan, T |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Taylor and Francis
2017
|
Registos relacionados
-
Personalised medicine: the promise, the hype and the pitfalls
Por: Feiler, T, et al.
Publicado em: (2017) -
Possibilities for personalised medicine in rheumatoid arthritis: hype or hope
Por: Pascal Hendrik Pieter de Jong, et al.
Publicado em: (2021-11-01) -
Biomarker-guided personalised emergency medicine for all – hope for another hype?
Por: Philipp Schuetz, et al.
Publicado em: (2015-02-01) -
The threat, hype, and promise of artificial intelligence in education
Por: Niklas Humble, et al.
Publicado em: (2022-11-01) -
Personalized medicine: hope or hype?
Por: Salari, K, et al.
Publicado em: (2012)